92 related articles for article (PubMed ID: 8521903)
1. Effects of putative cognition enhancers on the NMDA receptor by [3H]MK801 binding.
Hamelin SM; Lehmann JC
Eur J Pharmacol; 1995 Aug; 281(3):R11-3. PubMed ID: 8521903
[TBL] [Abstract][Full Text] [Related]
2. Putative cognition enhancers reverse kynurenic acid antagonism at hippocampal NMDA receptors.
Pittaluga A; Pattarini R; Raiteri M
Eur J Pharmacol; 1995 Jan; 272(2-3):203-9. PubMed ID: 7713164
[TBL] [Abstract][Full Text] [Related]
3. The "kynurenate test", a biochemical assay for putative cognition enhancers.
Pittaluga A; Vaccari D; Raiteri M
J Pharmacol Exp Ther; 1997 Oct; 283(1):82-90. PubMed ID: 9336311
[TBL] [Abstract][Full Text] [Related]
4. Manipulation of NMDA-receptor activity alters extinction of an instrumental response in rats.
Port RL; Seybold KS
Physiol Behav; 1998 Jun; 64(3):391-3. PubMed ID: 9748109
[TBL] [Abstract][Full Text] [Related]
5. Activity of putative cognition enhancers in kynurenate test performed with human neocortex slices.
Pittaluga A; Pattarini R; Andrioli GC; Viola C; Munari C; Raiteri M
J Pharmacol Exp Ther; 1999 Jul; 290(1):423-8. PubMed ID: 10381808
[TBL] [Abstract][Full Text] [Related]
6. Competitive antagonists and partial agonists at the glycine modulatory site of the mouse N-methyl-D-aspartate receptor.
Henderson G; Johnson JW; Ascher P
J Physiol; 1990 Nov; 430():189-212. PubMed ID: 1707965
[TBL] [Abstract][Full Text] [Related]
7. Anticonvulsant effects of the glycine/NMDA receptor ligands D-cycloserine and D-serine but not R-(+)-HA-966 in amygdala-kindled rats.
Löscher W; Wlaź P; Rundfeldt C; Baran H; Hönack D
Br J Pharmacol; 1994 May; 112(1):97-106. PubMed ID: 8032669
[TBL] [Abstract][Full Text] [Related]
8. Polyamine effects upon N-methyl-D-aspartate receptor functioning: differential alteration by glutamate and glycine site antagonists.
Nussenzveig IZ; Sircar R; Wong ML; Frusciante MJ; Javitt DC; Zukin SR
Brain Res; 1991 Oct; 561(2):285-91. PubMed ID: 1686987
[TBL] [Abstract][Full Text] [Related]
9. Different modes of action of 3-amino-1-hydroxy-2-pyrrolidone (HA-966) and 7-chlorokynurenic acid in the modulation of N-methyl-D-aspartate-sensitive glutamate receptors.
Danysz W; Fadda E; Wroblewski JT; Costa E
Mol Pharmacol; 1989 Dec; 36(6):912-6. PubMed ID: 2574820
[TBL] [Abstract][Full Text] [Related]
10. The glycine/NMDA receptor partial agonist D-cycloserine blocks kainate-induced seizures in rats. Comparison with MK-801 and diazepam.
Baran H; Löscher W; Mevissen M
Brain Res; 1994 Aug; 652(2):195-200. PubMed ID: 7953730
[TBL] [Abstract][Full Text] [Related]
11. Kynurenic acid analogues with improved affinity and selectivity for the glycine site on the N-methyl-D-aspartate receptor from rat brain.
Foster AC; Kemp JA; Leeson PD; Grimwood S; Donald AE; Marshall GR; Priestley T; Smith JD; Carling RW
Mol Pharmacol; 1992 May; 41(5):914-22. PubMed ID: 1375317
[TBL] [Abstract][Full Text] [Related]
12. D-cycloserine, a putative cognitive enhancer, facilitates activation of the N-methyl-D-aspartate receptor-ionophore complex in Alzheimer brain.
Chessell IP; Procter AW; Francis PT; Bowen DM
Brain Res; 1991 Nov; 565(2):345-8. PubMed ID: 1842701
[TBL] [Abstract][Full Text] [Related]
13. NMDA receptor antagonists that bind to the strychnine-insensitive glycine site and inhibit NMDA-induced Ca2+ fluxes and [3H]GABA release.
Reynolds IJ; Harris KM; Miller RJ
Eur J Pharmacol; 1989 Mar; 172(1):9-17. PubMed ID: 2541002
[TBL] [Abstract][Full Text] [Related]
14. EMD 95885, a new eliprodil analogue with higher affinity for the N-methyl-D-aspartate (NMDA) receptor.
Leibrock J; Prücher H; Rautenberg W
Pharmazie; 1997 Jun; 52(6):479-80. PubMed ID: 9260271
[No Abstract] [Full Text] [Related]
15. Effects of piracetam on N-methyl-D-aspartate receptor properties in the aged mouse brain.
Cohen SA; Müller WE
Pharmacology; 1993 Oct; 47(4):217-22. PubMed ID: 8234409
[TBL] [Abstract][Full Text] [Related]
16. Adaptive changes in the NMDA receptor complex in rat hippocampus after chronic treatment with CGP 39551.
Mennini T; Miari A; Presti ML; Rizzi M; Samanin R; Vezzani A
Eur J Pharmacol; 1994 Dec; 271(1):93-101. PubMed ID: 7698217
[TBL] [Abstract][Full Text] [Related]
17. Characterization of the effects of polyamines on the modulation of the N-methyl-D-aspartate receptor by glycine.
Reynolds IJ; Rothermund KD
Neuropharmacology; 1995 Sep; 34(9):1147-57. PubMed ID: 8532185
[TBL] [Abstract][Full Text] [Related]
18. 1-Hydroxy-3-aminopyrrolid-2-one (HA-966) and kynurenate antagonize N-methyl-D-aspartate induced enhancement of [3H]dopamine release from rat striatal slices.
Crawford M; Roberts PJ
Biochem Pharmacol; 1989 Dec; 38(23):4165-8. PubMed ID: 2688655
[TBL] [Abstract][Full Text] [Related]
19. Enhancement of NMDA-induced current by the putative NR2B selective antagonist ifenprodil.
Zhang XX; Bunney BS; Shi WX
Synapse; 2000 Jul; 37(1):56-63. PubMed ID: 10842351
[TBL] [Abstract][Full Text] [Related]
20. Arcaine uncovers dual interactions of polyamines with the N-methyl-D-aspartate receptor.
Reynolds IJ
J Pharmacol Exp Ther; 1990 Dec; 255(3):1001-7. PubMed ID: 2148185
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
